Tim H. Brümmendorf - Faculty of Medicine, RWTH Aachen University

基本信息

浏览量：57

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 16 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Asciminib Antagonizes Transplantable BCR::ABL1-positive Lymphoid Blast Crisis in Vivo by Targeting Malignant Stem Cells

Nicolas Chatain,Julian Baumeister,Marcelo A. Szymanski de Toledo,Dickson W. L. Wong,Siddharth Gupta,Kristina Pannen, Bärbel Junge,Tim H. Brümmendorf,Peter Boor,Steffen Koschmieder

Leukemiapp.1-6, (2024)

引用0浏览0WOSNATURE引用

Inherited Telomere Biology Disorders: Pathophysiology, Clinical Presentation, Diagnostics, and Treatment

Benjamin Rolles,Mareike Tometten, Robert Meyer,Martin Kirschner,Fabian Beier,Tim H Brümmendorf

Transfusion medicine and hemotherapy offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologieno. 5 (2024): 292-309

引用0浏览0WOS引用

Practical Considerations in the Management of Patients Treated with Bosutinib for Chronic Myeloid Leukemia

Jeffrey H. Lipton,Tim H. Brümmendorf,Kendra Sweet,Jane F. Apperley,Jorge E. Cortes

Annals of Hematology（2024）

引用0浏览0WOS引用

ABL001 (asciminib) Efficiently Targets Transplantable BCR::ABL1 Lymphoid Blast Crisis in the Scl-Tta-p210-BCR::ABL1 Mouse Model

Nicolas Chatain,Julian Baumeister, Marcelo Szymanski de Toledo,Dickson W.L. Wong,Siddharth Gupta,Kristina Pannen, Bärbel Junge,Tim H. Brümmendorf, Peter Boor, Steffen Koschmieder

Bloodno. Supplement 1 (2023): 4193-4193

引用0浏览0引用

Revised Supplemental Figures from Axl Blockade by BGB324 Inhibits BCR-ABL Tyrosine Kinase Inhibitor–Sensitive and -Resistant Chronic Myeloid Leukemia

Isabel Ben-Batalla,Robert Erdmann,Heather Jørgensen,Rebecca Mitchell,Thomas Ernst,Gunhild von Amsberg,Philippe Schafhausen, Janna L. Velthaus,Stephen Rankin, Richard E. Clark, Steffen Koschmieder,Alexander Schultze, Subir Mitra,Peter Vandenberghe,Tim H. Brümmendorf,Peter Carmeliet,Andreas Hochhaus,Klaus Pantel,Carsten Bokemeyer,G. Vignir Helgason,Tessa L. Holyoake,Sonja Loges

crossref（2023）

引用0浏览0引用

Clinicohematologic and Molecular Response of Essential Thrombocythemia Patients Treated with Pegylated Interferon-Α: a Multi-Center Study of the German Study Group-Myeloproliferative Neoplasms (GSG-MPN)

Frank Stegelmann,Lino L. Teichmann,Florian H. Heidel,Carl C. Crodel,Thomas Ernst,Sebastian Kreil,Andreas Reiter,Sara Otten,Stefanie Schauer,Ruth-Miriam Körber,Kim Kricheldorf,Susanne Isfort,Hartmut Döhner,Tim H. Brümmendorf,Martin Griesshammer,Konstanze Döhner,Steffen Koschmieder

LEUKEMIAno. 4 (2023): 924-928

引用1浏览0WOSNATURE引用

Eltrombopag Preserves the Clonogenic Potential of Hematopoietic Stem Cells During Treatment with Antithymocyte Globulin in Patients with Aplastic Anemia

Margherita Vieri,Benjamin Rolles, Maria Crocioni,Mirle Schemionek-Reinders,Susanne Isfort,Jens Panse,Tim H. Bruemmendorf,Fabian Beier

HemaSphereno. 6 (2023): e906-e906

引用0浏览0WOS引用

Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Antitumor Activity of the Cyclin-Dependent Kinase-9 (CDK9) Inhibitor AZD4573 in Relapsed/Refractory Hematological Malignancies: A Phase 1 First-in-Human Study

Tim H. Brummendorf,Patrick Medd,Raphael Koch,Stephan Stilgenbauer,Shringi Sharma, Yun He,Stefanie Meyer,Margaret C. Wey,Jamal Saeh,Richard F. Olsson,Arnon P. Kater

BLOOD（2022）

引用3浏览0引用

Targeting Cytokine-Induced Leukemic Stem Cell Persistence in Chronic Myeloid Leukemia by IKK2-inhibition

Marlena Bütow, Fabio J. Testaquadra,Julian Baumeister,Tiago Maié,Nicolas Chatain,Timo Jaquet,Stefan Tillmann,Martina Crysandt,Ivan G. Costa,Tim H. Brümmendorf,Mirle Schemionek

Haematologica（2022）

引用150浏览0引用

150

Antibody titers after SARS-CoV-2 mRNA vaccination in patients with aplastic anemia-A single-center study

Jeanette Walter,Kim Kricheldorf,Susanne Isfort,Tim H. Brummendorf,Jens Panse,Fabian Beier

EUROPEAN JOURNAL OF HAEMATOLOGYno. 6 (2022): 528-531

引用4浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn